Sulfoxides as substrate activators: New cross-couplings for making materials and medicines

Lead Research Organisation: University of Manchester
Department Name: Chemistry

Abstract

Synthetic chemistry is the engine that drives the advance of science and technology as man-made molecules and materials are vital to the work of millions of scientists around the world. In particular, the selective formation of carbon-carbon bonds, so-called 'cross-coupling', lies at the heart of almost any synthetic endeavour and is crucial for the discovery of tomorrow's pharmaceuticals, agrochemicals and advanced materials.

A suite of cross-coupling reactions using metal catalysts has been developed for carbon-carbon bond formation and these methods are routinely used in every chemistry laboratory in the world. The resulting, positive impact of cross-coupling technology on science and on society has been remarkable. Unfortunately, the majority of cross-coupling is mediated by platinum group metals (e.g. rhodium, palladium, iridium and platinum) and the supply of these costly metals is at risk, thus making their use unsustainable. It is against the backdrop of an uncertain future that the search for new cross-coupling methods that do not use a metal or use a low-cost metal catalyst has gripped the global synthetic community. The world's leading scientists now share a vision of a chemical community less reliant on platinum group metals.

There is an additional problem with the current methods for cross-coupling. Molecule-makers traditionally use starting, chemical feedstocks that are already 'functionalised'; i.e. they contain a 'handle' that facilitates chemical manipulation. If simpler, non-functionalised feedstocks could be used instead, shorter, less expensive chemical processes that generate less waste could be developed. With the promise of more sustainable chemistry in the future, the global synthetic community are eager to move away from 'functionalised' feedstocks to simpler starting materials that are functionalised and chemically transformed as part of a single process.

Finally, metal-free cross-coupling has an additional key benefit. Trace metal contamination in products arising from metal-catalysed processes is a major problem in industry, particularly the pharmaceutical and organic electronic industries, where products are for human consumption or for use in devices where performance can be compromised by 'undetectable' levels of metal contaminant.

In this project we will develop metal-free and low-cost metal catalysed cross-coupling processes that could eventually replace ubiquitous metal-catalysed technologies that use expensive platinum group metals. Our approach to this challenge is unique and is based on the proposal that sulfur can replace metals in; (i) activating substrates by functionalising them in situ, and (ii) providing a center around which coupling partners can be assembled prior to carbon-carbon bond-formation. More specifically, we will use readily-available and tuneable, organosulfur species, called sulfoxides, as reagents and catalysts to active simple feedstocks for direct use in new cross-couplings that deliver high value products. Crucially, our approach does not require pre-functionalised feedstocks for cross-coupling as activated substrates will be formed in situ and used directly in the same reaction vessel. At the heart of our proposal lies the so-called Interrupted Pummerer reaction, a little-known and seldom exploited chemical process in which a nucleophile adds to the sulfur of a sulfoxide to give a sulfonium salt. Our groundbreaking strategies will either be metal-free or will use inexpensive base-metal catalysts, thus avoiding the need for expensive, supply-risk, and contaminating platinum group metals.

Applications in the synthesis and modification of materials and pharmaceuticals will be used throughout the project to showcase the utility of our new technology to molecule makers and end-users, thus plotting a course to future impact. Our track record in innovative cross-coupling processes using sulfoxides leaves us uniquely placed to meet this challenge.

Planned Impact

The selective formation of carbon-carbon bonds, so-called cross-coupling, underpins almost every synthetic endeavour and is one of the most significant challenges that must be overcome when assembling tomorrow's pharmaceuticals, agrochemicals and industrial materials. As a result of this importance, a suite of metal-catalysed cross-coupling processes, familiar to every practising chemist worldwide, has been developed and the resultant benefits for society have been remarkable. More recently, the importance of a move away from pre-functionalised starting materials, to simpler, unfunctionalised feedstocks, has been widely recognised: Such starting materials are often more available, inexpensive and their use can result in processes that are highly atom-economical and generate less waste.

The majority of current cross-coupling protocols use platinum group metals (e.g. rhodium, palladium and platinum). Unfortunately, the supply of these expensive metals is at risk and their use will become unsustainable. An important future course, therefore, involves the development of cross-coupling processess that do not require a metal or that use an inexpensive base metal (e.g. nickel) in place of palladium, for example. Metal-free cross-coupling processes have additional benefits as trace metal contamination in products arising from metal-catalysed processes is a major problem in industry, particularly in the pharmaceutical and organic electronic industries, where products are for human consumption or for use in devices where performance can be compromised by trace metals.

In this project we will develop metal-free and low-cost metal catalysed cross-coupling processes that complement, and could eventually replace, ubiquitous metal-catalysed technologies that use expensive platinum group metals. More specifically, we will use sulfoxides as tuneable reagents and catalysts to activate simple, otherwise inert, feedstocks for direct use in new cross-couplings that deliver high value products. Crucially, our approach does not require pre-functionalised feedstocks for cross-coupling as activated substrates will be formed in situ and used directly in the same reaction vessel.

In the short term, the project will provide valuable, selective tools for synthetic chemists in their day-to-day work in industrial laboratories and plants. Our metal-free and low-cost metal-catalysed synthetic technology will allow chemists to improve future processes, streamline routes, lessen waste, and avoid the metal contamination of products. More specific industrial beneficiaries include the pharmaceutical, biotech, biopharmaceutical, agrochemical, organic electronic industries, and custom research organisations. It is important to note that the impact of our work will reach far beyond molecule-makers and end-users in Chemistry, and will extend to molecule end-users active in many disparate industrial areas. Our work is therefore expected to improve economic competitiveness and aid wealth creation in the UK. The timescale for impact will be short, with benefits beginning to arise 1-2 years after the completion of the project. In the long term, if alternative methods for cross-coupling are not developed, then, at some point in the future, our ability to make the molecules we need for industrial application and societal impact will be hindered by the scarcity of platinum group metals. Our established track record in synthetic method development and our nascent track record in the activation of substrates, using sulfoxides, for metal-free cross-couplings and low-cost metal-catalysis leaves us uniquely placed to meet the objectives of the project and to achieve the predicted impact.
 
Description We are developing new, more sustainable methods for cross-coupling that do not rely on the use of expensive and supply-risk precious metals.
Exploitation Route We envisage that industrial teams and academic teams will adopt our metal-free cross-coupling technology.
Sectors Agriculture, Food and Drink,Chemicals,Healthcare,Pharmaceuticals and Medical Biotechnology

 
Description We have developed new reagents that are now commerically-available.
First Year Of Impact 2022
Sector Chemicals,Healthcare,Pharmaceuticals and Medical Biotechnology
Impact Types Economic

 
Description Photoactivation of sulfonium salts in transition metal-free formal C-H/C-H-type couplings
Amount £118,513 (GBP)
Organisation AstraZeneca 
Sector Private
Country United Kingdom
Start 09/2021 
End 09/2025